Fengling Li
Impact in
- Molecular Biology top 2%
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- RNA modifications and cancer
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Biochemistry top 2%
- Lipid metabolism and biosynthesis
Papers in
-
- Epigenetics and DNA Methylation 36
- Cancer-related gene regulation 33
- RNA modifications and cancer 17
- Histone Deacetylase Inhibitors Research 9
- Advanced biosensing and bioanalysis techniques 8
- Biochemical and Molecular Research 6
- Protein Degradation and Inhibitors 6
- Ubiquitin and proteasome pathways 6
- Immunology 11
- Co-authors
- Masoud Vedadi (52 shared papers)C.H. Arrowsmith (34 shared papers)Peter J. Brown (26 shared papers)Ljerka Kunst (3 shared papers)Jian Jin (16 shared papers)Scott E. Plevy (10 shared papers)Huanquan Zheng (2 shared papers)Matthieu Schapira (15 shared papers)
- Journals
- Journal of Medicinal Chemistry (12 papers)SLAS DISCOVERY (6 papers)ACS Medicinal Chemistry Letters (6 papers)PLANT PHYSIOLOGY (4 papers)Scientific Reports (3 papers)
- Partner nations
- CanadaUnited StatesChina
In The Last Decade
Fengling Li
124 papers receiving 4.7k citations
Peers
Comparison fields: 5 of 141
- Molecular Biology 3.4k
- Biochemistry 285
- Cancer Research 319
- Immunology 429
- Plant Science 749
Countries citing papers authored by Fengling Li
This map shows the geographic impact of Fengling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengling Li more than expected).
Fields of papers citing papers by Fengling Li
This network shows the impact of papers produced by Fengling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengling Li. The network helps show where Fengling Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 314 | |
| 2 | 2013 | 206 | |
| 3 | 2009 | 202 | |
| 4 | 2015 | 192 | |
| 5 | 2014 | 173 | |
| 6 | 2009 | 146 | |
| 7 | 2014 | 142 | |
| 8 | 2018 | 119 | |
| 9 | 2012 | 114 | |
| 10 | 2011 | 112 | |
| 11 | 2010 | 110 | |
| 12 | 2015 | 109 | |
| 13 | 2010 | 103 | |
| 14 | 2013 | 98 | |
| 15 | 2004 | 95 | |
| 16 | 2003 | 88 | |
| 17 | 2019 | 82 | |
| 18 | 2007 | 79 | |
| 19 | 2014 | 74 | |
| 20 | 2007 | 73 |
About Fengling Li
Fengling Li is a scholar working on Molecular Biology, Immunology, Plant Science, Cancer Research and Oncology, having authored 129 papers that have together received 4.8k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (36 papers), Cancer-related gene regulation (33 papers), RNA modifications and cancer (17 papers), Histone Deacetylase Inhibitors Research (9 papers), Advanced biosensing and bioanalysis techniques (8 papers), Biochemical and Molecular Research (6 papers), Protein Degradation and Inhibitors (6 papers) and Ubiquitin and proteasome pathways (6 papers). The work is most often cited by research in Molecular Biology (3.4k citations), Biochemistry (285 citations), Cancer Research (319 citations), Immunology (429 citations) and Plant Science (749 citations). Fengling Li has collaborated with scholars based in Canada, United States and China. Frequent co-authors include Masoud Vedadi, C.H. Arrowsmith, Peter J. Brown, Ljerka Kunst, Jian Jin, Scott E. Plevy, Huanquan Zheng, Matthieu Schapira, Dalia Baršytė-Lovejoy and Reinhard Jetter. Their work appears in journals such as Journal of Medicinal Chemistry, SLAS DISCOVERY, ACS Medicinal Chemistry Letters, PLANT PHYSIOLOGY and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.